IL4 rs2070874: What Your Genotype Means for Allergies
The rs2070874 variant is a single nucleotide polymorphism located in the non-coding region of the interleukin-4 (IL4) gene on chromosome 5. Research suggests it may influence the regulation of IL-4 cytokine production and immunoglobulin E (IgE) synthesis. While associated with elevated IgE levels and susceptibility to allergic conditions like allergic rhinitis, overall scientific evidence remains limited and context-dependent.
What each genotype means
Common IL4 genotype
This is the most common genotype for this variant in many populations. Research has investigated this site for potential links to IgE levels and asthma risk, though findings are inconsistent across different ethnic groups and studies. It is not a diagnostic marker, and any concerns regarding respiratory health or allergies should be discussed with a healthcare provider.
This is the most frequent genotype observed in most studied populations, including those of European and African ancestry.
Associated with potential immune variation
Carriers of this genotype have one copy of the T allele, which some studies have associated with altered IL-4 expression and potential differences in asthma or allergy susceptibility. Because results are mixed and often depend on specific environmental or genetic backgrounds, this genotype does not predict a specific health outcome. Please consult with a clinician if you have concerns about allergic conditions.
This genotype is found in a significant portion of the population, occurring in roughly 1 in 3 to 1 in 4 individuals depending on ancestry.
Variant IL4 genotype
This genotype represents the homozygous state for the T allele, which has been studied for its potential role in modulating IgE levels and asthma risk. Some research suggests this genotype may be associated with different immune responses compared to the C allele, but evidence remains limited and conflicting. This is not a clinical diagnosis, and you should discuss any symptoms with your doctor.
This is the least common genotype for this variant, typically found in a small minority of individuals across most studied populations.
Genetic Architecture and Location
The single nucleotide polymorphism rs2070874 is positioned on chromosome 5 within the human interleukin-4 (IL4) gene locus, primarily categorized as an intron-1 or 5 prime untranslated/promoter-adjacent regulatory variant. Instead of altering an amino acid sequence directly, this C-to-T transition occurs within non-coding sequence architecture where transcription factor binding and transcriptional efficiency are modulated. Because it resides in a densely coordinated cytokine cluster that also harbors IL13 and IL5, rs2070874 frequently exists in linkage disequilibrium with neighboring immune-modulating loci. Genetic databases such as [NCBI dbSNP](https://www.ncbi.nlm.nih.gov/snp/rs2070874) catalog this variant as a common transition that serves as a potential regulatory marker rather than a protein-disrupting mutation. Consequently, any downstream immunological effects observed in carrier populations arise through altered gene expression kinetics or regulatory interactions rather than structural defects in the IL-4 protein itself.
The Biological Role of Interleukin-4
Interleukin-4 is a key signaling cytokine secreted predominantly by activated T helper type 2 (Th2) cells, basophils, and mast cells. It plays an essential role in orchestrating humoral immune defenses, promoting the differentiation of naive CD4+ T cells into mature Th2 effector cells. A hallmark function of IL-4 is driving antibody class switching in B lymphocytes toward immunoglobulin E (IgE). Under normal physiological conditions, IgE antibodies defend host tissues against parasitic helminths. However, in atopic individuals, inappropriate or exaggerated IL-4 signaling triggers excessive IgE production against harmless environmental antigens such as grass pollen, tree pollen, and animal dander. Variations that disrupt or elevate baseline IL-4 transcription can shift the delicate balance between protective immune defense and inflammatory hypersensitivity, placing cytokine genetics at the core of allergic disease biology.
Published Research and Evidence Strength
Multiple candidate-gene studies have evaluated rs2070874 for associations with atopic conditions, total serum IgE, and specific airway hypersensitivities. As documented in publications indexed on [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=rs2070874), studies of allergic rhinitis have observed that homozygous states correlate with altered clinical presentations and positive skin prick tests to tree and grass pollens. However, across the broader genomic literature, evidence for rs2070874 remains limited and characterized by mixed results. Some investigations describe a modest association between the variant alleles and higher circulating IgE or elevated risk for allergic disorders, whereas other cohorts fail to replicate these findings or find the signal eclipsed by broader genome-wide association study (GWAS) loci. Because most available findings derive from moderately sized candidate studies, rs2070874 is treated as a subtle susceptibility factor rather than an independent diagnostic marker.
Population Distribution and Ancestry Trends
The minor allele frequencies for rs2070874 demonstrate measurable differences across worldwide populations. In individuals of European ancestry, the T allele frequency is estimated at approximately 0.18, meaning that the C allele serves as the predominant major allele. In cohorts of African ancestry, the T allele occurs at a slightly higher frequency of roughly 0.22. Frequencies across other global populations, including Asian and Middle Eastern cohorts, show distinct local distributions and differing background haplotype structures. Because the phenotypic impact of non-coding regulatory polymorphisms often depends on background genetic ancestry and environmental allergen exposure, an association identified in one population cannot be directly assumed for another without localized validation.
Clinical Limitations and Personal Insights
Discovering your rs2070874 genotype provides an educational glimpse into cytokine genetics, but it cannot diagnose an allergy or predict whether you will experience seasonal symptoms. Complex allergic diseases like allergic rhinitis, atopic dermatitis, and asthma stem from hundreds of polygenic variants interacting with environmental triggers, including childhood allergen exposure, air pollution, and viral infections. A statistical association with elevated IgE does not guarantee high antibody titers or clinical symptoms. Consumers should never use personal genotype results to start, stop, or change allergy therapies, corticosteroids, or immunotherapy. Clinical allergy assessments require formal skin prick testing, blood tests, and medical evaluation by an allergist or immunologist.
How common is this variant?
The T allele frequency for rs2070874 is approximately 0.18 in European populations and 0.22 in African ancestry groups, with the C allele serving as the major allele globally.
Frequently asked questions
Does having the rs2070874 variant mean I have a pollen allergy?
No, carrying an associated allele does not mean you have or will develop a pollen allergy. The variant is only linked to modest statistical differences in IgE levels and sensitization risk in specific study cohorts. True allergic disease is diagnosed by clinical history and medical testing, not by single genetic markers.
What is the primary role of the IL4 gene in the body?
The IL4 gene provides instructions for making interleukin-4, a cytokine vital for immune signaling. IL-4 guides white blood cells called Th2 cells and directs B cells to produce immunoglobulin E (IgE) antibodies. While necessary for immune defense, excessive IL-4 activity can trigger allergic inflammation.
Why is the scientific evidence for rs2070874 considered limited?
Evidence is graded as limited because most findings stem from small or medium-sized candidate-gene studies rather than large, replicated genome-wide association studies. Many studies show mixed or modest results that vary across different ancestral backgrounds and geographic regions.
Can I use my rs2070874 genotype to guide allergy treatments?
No, your genotype cannot be used to select medications or alter treatment plans. Management of allergy symptoms should always be guided by a licensed physician or allergist based on clinical symptoms and standard diagnostic tests.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2070874?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL4
An intronic IL4 variant associated with heightened susceptibility to beta-lactam and penicillin immediate allergic reactions.
Variant within the IL4 gene region significantly associated with risk of penicillin hypersensitivity and immediate allergic reactions.
Promoter variant (C-590T) in IL4; while historically linked to IgE production and asthma, findings remain inconsistent across diverse ethnic populations.
Promoter polymorphism (-589C>T) that enhances IL-4 transcription and elevates total serum IgE, conferring heightened susceptibility to atopic dermatitis and allergic asthma.
Located in the Th2 cytokine locus between IL4 and KIF3A, this variant is robustly associated with overall food allergy risk independent of atopic dermatitis status.